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DNA	DAMAGE	IN	IN	VITRO	MATURED	OOCYTES	
ELISA	ATAMIAN	ABSTRACT		 The	reproductive	lifetime	of	a	woman	is	limited	primarily	by	her	age.	The	state	of	an	oocyte	represents	the	central	determinant	of	the	fate	of	an	ovarian	follicle	as	well	as	embryo	development	throughout	maturation.	Oocyte	reserve	and	oocyte	quality	are	two	major	determinants	of	the	likelihood	of	achieving	pregnancy	for	a	woman.	Assisted	Reproductive	Technology	(ART)	has	provided	a	valuable	alternative	for	women	attempting	to	conceive	at	an	older	age,	however	even	with	ART	the	likelihood	of	a	live	birth	also	decreases	with	increased	age.			 Mammalian	oocytes	undergo	meiotic	maturation	in	preparation	for	ovulation	and	fertilization.	Throughout	most	of	its	lifetime	the	oocyte	remains	arrested	in	the	dictyate	stage	of	prophase	of	meiosis	I	(MI),	also	called	the	germinal	vesicle	(GV)	stage,	until	the	follicle	receives	a	hormonal	signal	to	progress	through	meiosis.	Only	a	small	fraction	of	the	follicles	present	in	the	ovaries	receive	this	signal,	while	the	rest	remain	unresponsive.		The	DNA	damage	response	(DDR)	is	activated	in	the	presence	of	double	stranded	breaks	(DSBs)	in	DNA	and	can	induce	various	cellular	responses	including	senescence	or	cell	cycle	arrest,	and/or	apoptosis,	also	known	as	programmed	cell	death.	Telomeres	mediate	senescence	in	most	cells.	Telomeres	consist	of	tandem	DNA	repeats	and	associated	proteins,	which	cap	and	protect	chromosome	ends.	Telomeres	and	their	associated	proteins	form	a	loop	at	the	ends	of	chromosomes,	
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which	buries	them.	This	telomere	complex	is	called	shelterin.	Shelterin	prevents	the	ends	of	chromosomes	from	triggering	a	DNA	damage	response.	However,	with	each	round	of	DNA	replication	chromosomes	lose	small	segments	of	their	telomeres.	Telomere	attrition	also	can	arise	in	non-dividing	cells	via	the	action	of	oxygen	radicals.		 We	hypothesize	that	germinal	vesicle	arrest,	which	occurs	in	some	oocytes	retrieved	for	ART	that	fail	to	progress	through	meiosis,	is	associated	with	telomere	attrition	and	the	associated	cellular	senescence	pathway	induced	by	DNA	damage.	Previous	studies	have	identified	higher	levels	of	DNA	damage	foci	in	isolated	GV	arrested	oocytes	compared	to	those	that	progress	through	the	meiotic	cell	cycle.	Our	studies	confirm	the	presence	of	the	DNA	damage	response	(DDR)	regulator,	ATM,	at	higher	levels	in	GV	stage	oocytes	versus	those	that	have	matured	to	later	stages.	Immunostaining	shows	a	near	50%	increase	in	presence	of	ATM	in	arrested	oocytes.			 Confirming	the	role	of	the	DDR	in	cell	cycle	arrest	during	oocyte	maturation	could	highlight	a	new	target	for	strategies	to	improve	ART	technology	and	increase	the	likelihood	of	achieving	pregnancy	later	in	life.			 	
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INTRODUCTION	
Reproductive	Aging		 The	reproductive	lifespan	of	a	woman	is	limited	primarily	by	her	age.	The	female	reproductive	capacity	peaks	by	her	early	20s	after	which	it	begins	to	decline	from	her	30s,	until	it	eventually	leads	to	sterility	about	ten	years	before	menopause.	The	mechanisms	driving	the	age	related	decline	in	fertility,	while	women	still	have	primary	follicles	in	their	ovaries,	remains	poorly	understood.			 One	factor	contributing	to	age	related	reproductive	decline	is	a	decrease	in	ovarian	reserve,	i.e.	the	total	number	of	available	oocytes,	throughout	a	woman’s	lifetime.	The	oogonial	stem	cell	population	halts	proliferation	prior	to	birth	leading	to	a	fixed	amount	of	primordial	follicles	available	throughout	the	reproductive	lifetime	(Faddy	&	Gosden,	1996).	Of	the	nearly	7	million	follicles	available	during	the	second	trimester	of	a	female	fetus’s	life,	only	around	500,000	survive	to	puberty.	Around	500	follicles	ovulate	throughout	a	woman’s	lifetime.	The	rest	undergo	atresia.	Fertility	peaks	during	the	mid-twenties,	and	then	declines	steeply	beginning	at	age	35	paralleling	the	exponential	decrease	in	follicle	number	(Hansen	et	al.,	2008)	(Figure	1).	Menopause	begins	when	only	a	few	hundred	follicles	remain	(Thomford,	Jelovsek,	&	Mattison,	1987).	Moreover,	marker	of	ovarian	reserve,	such	as	basal	follicle	stimulating	hormone	(FSH),	antral	follicle	count	and	anti-mullerian	hormone	(AMH),	only	poorly	predict	fertility.	Thus,	the	age	related	decrease	in	infertility	cannot	be	explained	solely	by	diminished	ovarian	reserve.	
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	 While	the	decline	in	female	fertility	precedes	menopause	by	nearly	10	years,	menstrual	cycles	continue	to	occur	monthly.	However	the	developmental	capacity	of	oocytes,	called	oocyte	quality,	declines.	This	becomes	apparent	when	women	experience	increasing	difficulty	achieving	pregnancy	after	their	late	30s.	Between	ages	of	35	and	40,	a	woman’s	chances	of	achieving	pregnancy	within	a	year	declines	from	66%	to	44%,	leading	to	most	women	meeting	the	criteria	for	the	definition	of	“infertility”.	(Leridon,	2004)	(Figure	1)		
	
Figure	1:	Varying	factors	reflecting	decline	in	fertility	in	aging	women.	As	maternal	age	increases	the	number	of	non-growing	follicles	available	for	maturation	decreases,	along	with	the	chances	of	a	live	birth.	An	increased	rate	of	miscarriage	and	aneuploidy	is	also	seen.	Donor	pregnancy	rates	are	shown	to	restore	pregnancy	
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rates	to	those	of	younger	aged	women.	(Kalmbach,	Antunes,	Kohlrausch,	&	Keefe,	2015)		
 One	of	the	major	causes	of	ovarian	aging	is	increased	aneuploidy,	or	abnormal	number	of	chromosomes.	Lethal	aneuplodies	lead	to	failed	implantation	and	miscarriage.	Consequently,	the	likelihood	of	achieving	a	live	birth	declines	dramatically	with	age,	until	age	43	when	most	women	are	sterile	(Hassold,	Hall,	&	Hunt,	2007)	(Figure	1).		 Women	increasingly	postpone	attempts	at	childbearing.	The	average	age	of	becoming	a	first	time	mother	increased	in	recent	years.	Also,	the	percentage	of	women	seeking	alternative	methods	of	achieving	pregnancy	has	increased	significantly	(Matthews	&	Hamilton,	2014). Increasingly women turn to Assisted	Reproductive	Technology	(ART)	to	achieve	pregnancy.	In	some	developed	countries,	such	as	Denmark	and	Israel,	up	to	four	percent	of	babies	are	conceived	by	ART.		
Assisted	Reproductive	Technology	The	average	age	of	first-time	mothers	has	increased	significantly	over	the	past	3	decades	and	the	proportion	of	first	births	to	women	over	the	age	of	35	has	increased	nearly	eight	times	since	1970.	(Matthews	&	Hamilton,	2009)	As	an	increasing	proportion	of	women	in	industrialized	countries	delay	their	first	attempts	at	achieving	pregnancy,	more	women	are	using	Assisted	Reproductive	Technology	(ART)	procedures	to	address	their	decreased	fertility	rates.	(SART)		
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Currently	most	fertility	centers,	including	the	New	York	University	Fertility	Center	(NYUFC),	utilize	controlled	ovarian	hyperstimulation	(COH)	to	maximize	the	number	of	mature	oocytes	available	for	retrieval	per	cycle.	These	protocols	utilize	exogenous	gonadotropins,	to	monitor	and	control	the	ovarian	environment	by	promoting	follicle	development	and	increasing	the	number	of	eggs	available	for	fertilization.	(Pacchiarotti	et	al.,	2016)	An	appropriate	dosage	is	required	to	avoid	either	Ovarian	Hyperstimulation	Syndrome	(OHS)	or	insufficient	number	of	oocytes	available.	(La	Marca	et	al.,	2012)	Two	methods	are	currently	used	to	fertilize	eggs.	The	first	method,	in	vitro	fertilization	(IVF),	incubates	sperm	and	eggs	in	a	culture	dish.	The	second	method,	intracytoplasmic	sperm	injection	(ICSI),	injects	sperm	directly	into	the	egg	cytoplasm.	After	several	days	of	culture	in	vitro	the	embryos	either	are	transferred	to	the	uterus	with	careful	timing	or	frozen	for	future	transfer.	The	fertilized	oocyte	begins	its	first	rounds	of	mitotic	division.	Transfer	of	the	embryo	is	conducted	either	during	the	early	stages	of	cleavage	(day	3	post	fertilization)	or	at	the	blastocyst	stage	of	development	(day	5	post	fertilization)	(Figure	2)	(Lonergan	&	Fair,	2016).		
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Figure	2:	Duration	of	routine	human	IVF:	Processes	occurring	during	human	IVF	including	oocyte	maturation,	fertilization,	and	culture	prior	to	embryo	transfer	or	freezing.	(Lonergan	&	Fair,	2016)		 A	woman’s	age	is	the	most	important	factor	determining	her	chances	of	achieving	pregnancy	using	ART	procedures.	The	average	age	of	women	who	had	ART	cycles	during	2013	using	fresh	non-donor	eggs	was	around	35,	while	66%	were	ages	30-39,	and	23%	were	ages	40	or	older.	As	a	woman	ages,	the	likelihood	of	a	successful	response	to	ovarian	stimulation,	progression	to	egg	retrieval,	and	embryo	development	all	decrease.	Additionally,	embryos	that	implant	are	more	likely	to	miscarry	with	advancing	maternal	age.	(Figure	3)	(CDC,	2013)	
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Figure	3:	Outcomes	of	ART	Cycles	using	Fresh	Nondonor	Eggs	or	Embryos,	by	
Stage	and	Age	Group:	The	likelihood	of	a	successful	outcome	of	ART	decreases	with	every	step	of	the	process	as	a	woman	ages	from	below	the	age	of	35	to	above	the	age	of	44.	(CDC,	2013)		
Oocyte	Maturation		 Prior	to	successful	fertilization	the	oocyte	must	undergo	meiotic	maturation.	Meiosis	is	a	process	exclusive	to	gametes,	which	consists	of	one	round	of	replication	and	two	rounds	of	segregation.	The	first	round	separates	homologous	chromosomes.	The	second	round	separates	chromatids,	to	produce	haploid	gametes.	(Whitaker,	1996)	During	meiosis	the	oocyte	arrests	at	two	different	steps.	
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These	cell	cycle	arrests	are	broken	by	the	LH	surge	triggering	ovulation,	and	by	the	fertilizing	sperm.	(Whitaker,	1996)	Meiosis	begins	when	oogonia	stop	dividing	and	enter	meiosis.	These	primary	oocytes	arrest	at	the	germinal	vesicle	(GV)	stage	or	prophase	of	meiosis	I	(Lei	&	Spradling,	2013).	The	oocytes	can	remain	arrested	at	this	diplotene	stage	for	up	to	50	years,	until	they	are	committed	to	either	ovulation	or	undergo	atresia.	(Picton,	Briggs,	&	Gosden,	1998)	At	this	stage	a	single	layer	of	pregranulosa	cells	on	a	basement	membrane	surrounds	the	oocyte.	This	complex	is	termed	the	primordial	follicle.	At	this	stage	the	oocyte	DNA	content	is	2n	but	4C,	i.e.	it	contains	four	times	the	haploid	complement	of	DNA.	(Figure	5)	The	action	of	maturation-promoting	factor	(MPF),	a	complex	consisting	of	cyclin-dependent	kinase	1	(CDK1)	and	cyclin	B,	controls	the	arrest	of	oocytes	at	the	GV	stage.	Dephosphorylation	of	MPF	by	cdc25	induces	MPF	activation,	which	peaks	during	meiosis	I.	(Figure	4)	
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Figure	4:	Oocyte	Maturation	in	Vivo.	During	development	oocytes	become	arrest	at	the	germinal	vesicle	stage	with	a	2n,	4C	DNA	content.	The	LH	surge	leads	to	progression	through	meiosis	and	arrest	at	the	metaphase	II	(M2)	stage,	as	the	first	polar	body	(PB)	is	extruded.	Penetration	of	the	sperm	results	in	extrusion	of	the	second	PB,	and	establishment	of	a	1n,	1C	DNA	state	in	the	oocyte.	Fertilization	results	in	a	diploid	embryo	(2n,	2C).	(Lonergan	&	Fair,	2016)			
	
Figure	5:	Interaction	of	regulators	of	cell	cycle	during	meiotic	maturation.	Immature	oocytes	characterized	by	a	GV,	are	arrested	at	prophase	of	meiosis	I	(MI).	Meiosis	is	reinitiated	by	a	hormonal	signal,	leading	to	GVBD	and	two	phases	of	
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meiosis	(MI	and	MII)	resulting	in	haploid	cells	due	to	the	lack	of	an	S	phase	between.	(Kishimoto,	2003)			 Meiosis	is	resumed	in	vivo	following	the	preovulatory	surge	of	Luteinizing	Hormone	(LH).	This	LH	surge	results	in	the	breakdown	of	the	nuclear	envelope	of	the	oocyte	or	germinal	vesicle	breakdown	(GVBD),	as	well	as	various	other	cytological	changes.	In	addition,	the	first	polar	body,	which	contains	one	of	each	pair	of	homologous	chromosomes,	is	extruded.	The	oocyte	progresses	to	metaphase	II	of	meiosis	and	arrests	again.	Around	one	day	later	the	oocyte	is	ovulated	and	ready	for	fertilization.	If	it	is	fertilized	the	oocyte	completes	meiosis	and	begins	to	divide	continuously	to	initiate	embryonic	development.	(Picton,	Briggs,	&	Gosden,	1998)	(Lonergan	&	Fair,	2016)	(Figure	5)	Oocyte	maturation	is	a	prolonged	process	that	occurs	successfully	only	for	a	small	portion	of	the	oocytes	available	in	the	ovaries.	Immature	oocytes,	characterized	by	the	presence	of	a	GV,	limit	reproductive	performance	in	both	spontaneous	and	IVF	cycles	(Figure	5).	Oocytes	arrested	at	the	GV	stage,	premature	GVBD,	and	persistence	of	meiotic	arrest	in	prophase	I	lead	to	a	decreased	chance	of	pregnancy.	(Aydin,	Celik,	Celik,	Gungor,	&	Haberal,	2015)			
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Figure	6:	Antral	follicle	containing	primary	oocyte	arrested	in	prophase	of	
Meiosis	I.	Immature	oocyte	arrested	at	germinal	vesicle	stage	of	maturation.		 A	study	of	the	factors	involved	in	the	senescence	of	oocytes	at	the	immature	GV	stage	can	provide	insight	into	factors	affecting	ovarian	aging	and	the	decline	in	fertility	rates	after	the	age	of	30.	Cellular	senescence	has	been	linked	to	aging	and	age-related	diseases.	Senescence	is	induced	by	multiple	factors,	one	of	which	is	nuclear	DNA	damage	creating	stress	on	the	cell.	(Campisi	&	d’	Adda	di	Fagagna,	2007)		
Oocyte	Developmental	Competence	The	marked	decline	in	natural	fertility	as	well	as	in	ART	pregnancy	rates	after	the	age	of	35	can	be	explained	by	poor	oocyte	quality	rather	than	uterine	contribution	to	implantation	failure.	Various	factors,	including	chromosomal	integrity,	mutations	and	deletions	in	mitochondrial	DNA,	meiotic	spindle	
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abnormalities,	incomplete	separation	of	sister	chromatids,	and	telomere	DNA	attrition,	have	been	shown	to	influence	oocyte	quality.	As	women	age	rates	of	meiotic	nondisjunction	increase	markedly,	resulting	in	increased	aneuploidy	during	the	early	stages	of	embryo	development.	This	is	characterized	not	only	by	atypical	number	of	chromosomes	in	pre-implantation	embryos,	but	also	in	offspring.	For	example	Down’s	syndrome,	caused	by	trisomy	21,	results	from	meiotic	non-disjunction	in	over	80%	of	cases	and	increases	with	maternal	age.	For	older	women	nearing	the	end	of	their	reproductive	lifespans,	typically	all	embryos	are	aneuploid.	Genetic	abnormalities	in	the	early	stages	of	meiosis	are	much	more	detrimental	than	faults	at	later	stages,	resulting	in	much	more	extensive	aneuploidy	and	more	extensive	damage.	(Nagaoka,	Hassold,	&	Hunt,	2012)	 Donation	of	oocytes	from	younger	women,	overcomes	age-related	infertility	thus	establishing	that	poor	oocyte	quality	rather	than	uterine	factors	is	responsible	for	the	age-related	reduction	in	fertility.	ART	using	the	woman’s	own	oocytes,	however,	only	partly	reduces	the	fertility	gap	caused	by	postponing	attempts	at	pregnancy	past	age	35.	(Leridon,	2004)	Transfer	of	an	euploid	embryo	following	preimplantation	genetic	screening	(PGS)	produces	fertility	rates	comparable	to	oocyte	donation,	suggesting	that	chromosomal	nondisjunction	is	centrally	involved	in	the	decline	in	oocyte	competence	with	aging.	(Forman,	Hong,	Franasiak,	&	Scott	Jr.,	2014)	
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	 In	addition	to	chromosomal	abnormalities,	the	oocyte	is	highly	susceptible	to	various	levels	of	DNA	damage,	both	at	the	nuclear	and	mitochondrial	level.	The	arrest	of	the	oocyte	in	prophase	of	meiosis	I	makes	it	increasingly	susceptible	to	DNA	damage,	which	can	lead	to	infertility	or	genetic	abnormalities.	(Jacquet,	Adriaens,	Buset,	Neefs,	&	Vankerkom,	2005)	The	body’s	DNA	damage	response	(DDR)	protects	the	genome	integrity	of	cells,	however	little	is	known	of	this	mechanism	in	oocytes.	If	DNA	damage	is	not	successfully	repaired,	cells	enter	senescence	or	undergo	apoptosis.			
DNA	Damage	Response	and	Cellular	Senescence		 During	the	cell’s	lifespan	various	stresses	challenge	its	genomic	integrity.	Cells	have	evolved	a	complex	and	organized	pathway	to	amend	genomic	stress	called	the	DNA	damage	response	(DDR).	The	DDR	senses	DNA	damage,	arrests	the	cell	cycle,	employs	repair	mechanisms,	and/or	eliminates	cells	with	permanently	damaged	genomes.	The	DDR	signal	transduction	pathway	is	driven	primarily	by	phosphorylation	of	various	proteins	that	carry	out	the	pre-determined	downstream	processes.	(Maréchal	&	Zou,	2013)		Double-stranded	breaks	in	DNA	(DSBs)	arise	from	incorrect	DNA	replication,	cell-cycle	deregulation,	cellular	metabolism,	especially	oxygen	radicals,	or	exogenous	genotoxic	stress	such	as	ionizing	irradiation.	(Bzymek,	Thayer,	Oh,	Kleckner,	&	Hunter,	2010)	At	a	low	level,	cells	may	adapt	to	the	damage	created	by	DSBs,	trigger	apoptosis	or	inactivate	an	essential	gene	necessary	for	cellular	
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senescence,	which	predisposes	to	malignant	transformation	(Khanna	&	Jackson,	2001).	DSBs	in	DNA	occur	physiologically	during	meiotic	recombination	in	oocytes	prior	to	their	arrest	at	the	GV	stage.	DDR	mechanisms	have	evolved	to	ensure	that	when	DNA	damage	takes	place	at	other	times,	the	damage	is	detected	and	the	cell	cycle	is	arrested	to	allow	the	repair	process	to	occur.			 A	complex	consisting	of	MRE11,	RAD50	and	NBS1	(MRN)	initially	senses	DSBs.	This	complex	plays	an	essential	role	in	DNA	damage	repair.	MRN	is	responsible	for	sensing	and	binding	to	DSBs	and	recruiting	and	activating	Ataxia	telangiectasia	mutated	(ATM)	kinase.	(Figure	5)	(Carson,	2003)	ATM	phosphorylates	histone	H2AX	at	serine	139	at	the	sites	of	damage.	(Burma,	Chen,	Murphy,	Kurimasa,	&	Chen,	2001)	Following	phosphorylation,	mediator	DNA	damage	checkpoint	protein	(MDC1)	interacts	with	γH2AX	to	recruit	more	MRN	complexes	to	the	site	of	damage.		
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Figure	7:	The	MRN	complex	senses	and	binds	to	DSBs:	MRE11,	Rad50,	and	NBS1	work	as	a	complex	to	sense	and	bind	to	broken	ends	of	DNA	subsequently	recruiting	ATM	and	other	DDR	proteins.	(Lavin,	2008)			 MRN	promotes	the	repair	of	DSBs	during	meiotic	recombination	through	multiple	pathways	including	homologous	recombination,	non-homologous	end	joining,	and	alternative	non-homologous	end	joining.	(Mayer	et	al.,	2016)	MRN	also	plays	a	structural	role	in	the	DDR,	by	creating	a	bond	between	the	tethered	strands	of	DNA,	and	by	promoting	the	resection	of	the	DSB	ends.	(Stracker	&	Petrini,	2011)		ATM	activation	is	known	to	be	the	primary	step	in	the	establishment	of	the	G2	phase	checkpoint	in	the	presence	of	DSBs.	(Maréchal	&	Zou,	2013)	ATM	proceeds	to	phosphorylate	and	activate	transducer	checkpoint	kinases	1	and	2	(CHK1	and	CHK2),	which	in	turn	phosphorylate	various	effector	proteins	involved	in	DNA	repair	and	cell	cycle	arrest.	(Ciccia	&	Elledge,	2010)		
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One	main	target	of	ATM	in	the	DDR	pathway	is	p53,	which	is	activated	and	stabilized	via	phosphorylation	on	many	sites.	By	enhancing	the	activity	of	p53	as	a	transcription	factor,	the	CDK2-cyclin-E	inhibitor	gene	is	transcribed,	also	known	as	p21.	(Figure	6)(Shiloh,	2003)	Both	p53	and	p21	are	hallmarks	of	DNA	damage	induced	cellular	senescence	or	growth	arrest.	(Campisi	&	d’	Adda	di	Fagagna,	2007)	Senescent	cells	are	characterized	by	nuclear	DNA	damage	foci,	senescence-associated	heterochromatin	foci	(SAHFs),	increase	in	cell	size,	loss	of	nuclear	HMGB1,	and	decreased	expression	of	lamin	B1.	Additionally	they	express	the	senescence-associated	secretory	phenotype	(SASP),	which	collectively	includes	pro-inflammatory	cytokines,	growth	factors,	and	matrix	metalloproteinases.	(Coppé	et	al.,	2008)	Cellular	senescence	may	have	beneficial	effects	by	preventing	cancerous	or	damaged	cells	from	dividing.	However	senescence	can	also	be	deleterious	and	has	been	linked	to	age-related	pathologies.	Thus	senescence	has	emerged	as	an	appealing	target	for	therapeutic	strategies.		(Childs,	Durik,	Baker,	&	van	Deursen,	2015)	 	
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Figure	8:	ATM	mediated	activation	of	cell-cycle	checkpoints	in	response	to	
DSBs.	ATM	very	precisely	controls	a	multitude	of	substrates	that	are	responsible	for	activating	the	cell-cycle	checkpoints.	Complex	pathways	of	phosphorylation	and	dephosphorylation			 	
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DNA	Damage	Response	in	Oocytes	DNA	integrity	in	oocytes	is	critical	for	successful	reproduction.	Previous	experiments	in	mouse	oocytes	have	shown	that	H2AX	is	phosphorylated	during	the	DDR	in	response	to	DSBs,	forming	γH2AX	foci.	However,	increased	DNA	damage	typically	does	not	prevent	entry	of	the	oocyte	into	M	phase	of	meiosis	I	due	to	a	limited	DDR	in	oocytes.	Despite	the	presence	of	DNA	damage,	one	experiment	found	that	oocytes	were	able	to	undergo	GVBD	and	enter	M	phase	almost	normally.	The	lack	of	an	effective	DNA	damage	checkpoint	suggests	that	oocytes	may	not	depend	upon	the	ATM	kinase.	(Marangos	&	Carroll,	2012)		Recent	data	shows	that	during	MI,	the	phosphorylation	of	H2AX	is	independent	of	ATM.	This	suggests	that	other	effector	proteins	may	be	responsible	for	regulation	of	H2AX	and	its	role	in	cell-cycle	progression.	MRE11	has	been	found	to	be	involved	in	H2AX	phosphorylation,	and	maintenance	of	genome	integrity	during	oocyte	maturation.	(Mayer	et	al.,	2016)		The	DDR	in	human	oocytes	have	been	much	less	studied.	It	is	unclear	whether	permanent	arrest	at	the	GV	stage	in	human	oocytes	is	even	linked	to	the	cellular	senescence	pathway.	The	role	of	ATM	activation,	as	occurs	in	somatic	cells	in	response	to	increased	DNA	damage,	has	been	even	less	studied	in	the	human	oocyte.			 	
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SPECIFIC AIMS 		 The	current	lack	of	knowledge	regarding	the	permanent	arrest	of	oocytes	at	the	GV	stage	presents	a	critical	barrier	to	understanding	ovarian	aging	and	the	decline	in	fertility	in	older	women.	ART	technology	has	provided	a	groundbreaking	alternative	for	women	attempting	to	achieve	pregnancy,	but	also	it	provides	access	to	study	human	oocytes.		The	DDR	affects	the	ability	of	mouse	oocytes	to	progress	past	cell	cycle	checkpoints	during	meiosis	in	response	to	DSBs.	As	the	majority	of	oocytes	remain	arrested	in	their	immature	state	throughout	most	of	a	woman’s	reproductive	lifetime,	the	DDR	may	be	involved	in	the	maintenance	of	cell	senescence.	ATM,	a	central	regulator	of	cell	cycle	progression	in	somatic	cells,	may	be	involved	in	this	arrest	by	activating	the	cellular	senescence	pathway.	Previous	findings	have	shown	that	other	factors	besides	ATM	are	responsible	for	the	detection	of	DSBs	in	mouse	oocyte	DNA,	including	MRE11	and	ATR,	but	the	story	in	human	oocytes	remains	to	be	told.		Our	current	study	aims	to	test	the	hypothesis	that	GV	arrest	in	isolated	human	oocytes	is	associated	with	an	increased	amount	of	DNA	damage	compared	to	oocytes	in	later	stages	of	maturation,	which	activates	the	cellular	senescence	pathway.	To	test	the	hypothesis	we	will:	
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1. Compare	presence	of	DDR	marker,	ATM,	during	latest	stages	of	oocyte	development	with	those	that	did	not	successfully	mature	in	vitro	past	the	GV	stage.	2. Evaluate	levels	of	ATM-P,	the	phosphorylated	and	active	version	of	ATM,	in	GV	arrested	oocytes	versus	M1/M2	oocytes.	3. Examine	the	expression	of	DDR	markers	at	chromosomes	versus	in	the	cytoplasm.			 These	studies	will	define	a	role	of	the	DDR,	particularly	the	serine/threonine	protein	kinase	ATM,	in	cellular	senescence	at	prophase	of	meiosis	I.					
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METHODS	
Sample	Collection	The	Fertility	Center	(FC)	of	New	York	University	Langone	Medical	Center	(NYULMC)	routinely	performs	IVF	for	numerous	patients	with	infertility.	Patients	underwent	gonadotropin/	antagonist	cycles	for	in	vitro	fertilization	(IVF)	with	intra-cytoplasmic	sperm	injection	(ICSI)	or	elective	oocyte	freezing	with	vitrification.	Retrieved	oocytes	stripped	of	cumulus	cells	were	assessed	for	maturity	prior	to	use	for	ICSI	or	oocyte	vitrification.	Rather	than	discard	oocytes	found	to	be	at	GV	stage(N=	28),	we	cultured	them	in	Global	for	Fertilization	Media	(G2,	Life	Global®)	and	monitored	them	in	culture	for	48	hours	post	retrieval.	Oocytes	were	cultured	in	a	CO2	incubator	that	maintained	cells	at	37	degrees	in	5%	oxygen.	(Table	1)	Early	oocyte	development	was	examined	and	morphological	patterns	of	in	vitro	maturation	(IVM)	were	noted.	Oocytes	arrested	at	the	GV	stage	after	a	24-hour	period	were	separated	from	those	that	progressed	to	either	the	M1	or	M2	stage.	Samples	were	processed	separately	based	on	patient	and	stage	of	maturation.		
Table	1.	Conditions	for	Oocyte	Incubation:	Temperature	 	37°C	𝑪𝑶𝟐	Levels	 5%		
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Fixation	Both	GV	and	M1/M2	samples	were	first	fixed	in	a	paraformaldehyde	(PFA)	solution.	This	solution	consists	of	0.1	g	of	PFA	in	10	mL	of	0.1%	PBS-PVP	solution.	The	solution	was	incubated	in	a	waterbath	heated	to	50-60℃	for	20	minutes	or	until	the	PFA	was	completely	dissolved.	The	solution	was	then	filtered	with	a	0.45𝜇𝑔	filter	to	remove	any	undissolved	PFA.	After	washing	the	oocyte	twice	in	0.1%	PBS-PVP	stock,	the	GV/MII	sample	was	placed	into	the	PFA	solution	for	15	minutes	in	the	first	well	of	a	96	well	plate	and	placed	on	ice.	The	zona	pellucida	was	not	removed.	
Permeabilization	After	a	brief	wash,	oocytes	were	placed	in	a	blocking	solution	consisting	of	3%	goat	serum,	0.1%	Bovine	Serum	Albumin	(BSA)	in	PBS.	Oocytes	were	transferred	to	a	permeabilization	solution	for	30	minutes.	This	solution	consists	of	0.1%	Triton	X-100	in	blocking	solution,	to	permeabilize	the	nuclear	membrane	to	allow	the	reagents	to	have	access	to	the	DNA	contained	within.	Oocytes	were	then	washed	in	three	separate	wells	of	blocking	solution	for	15	minutes	each.		
Immunofluorescence	and	Confocal	Microscopy	After	three	consecutive	washes	in	blocking	solution,	oocytes	were	transferred	into	the	appropriately	diluted	primary	antibody	dissolved	in	PBS.	Various	primary	antibodies	were	used	to	assess	the	level	of	DNA	Damage	Response	occurring	within	the	GVs	or	MIIs.	(Table	1)	The	samples	were	incubated	overnight	in	the	antibody	at	4°C.	After	washing	the	oocytes	in	blocking	solution,	three	times	
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for	15	minutes	each,	the	oocytes	were	incubated	with	secondary	antibody	for	one	hour	at	room	temperature	and	away	from	light.		ATM	was	detected	by	rabbit	polyclonal	antibody	(Abcam,	ab82512),	and	ATM-Phosphorylated	(ATM-P)	by	rabbit	monoclonal	antibody	(Abcam,	ab81292).	All	primary	antibodies	were	used	at	a	dilution	of	1:200.	Anti-rabbit	antibodies	were	conjugated	with	Texas	Red	Goat	Anti-Rabbit	antibody	(Vector	Labs,	TI-1000).	Control	oocytes	were	stained	with	Texas	Red,	in	a	1:200	dilution,	without	prior	incubation	with	a	primary	antibody,	to	serve	as	negative	controls.	Control	images	showed	no	signs	of	red	foci.		The	oocytes	were	then	washed	in	blocking	solution	again,	three	times	for	15	minutes	each.	After	an	ultimate	wash	in	0.1%	PBS-PVP	the	oocyte	was	placed	on	a	slide	in	a	5-μl	drop	of	Vectashield,	a	mounting	medium	used	for	preserving	fluorescence,	(Vector	H1000)	and	Vectashield	with	DAPI,	a	nuclear	counterstain,	(Vector	H-1200)	in	a	4:1	ratio	for	DNA	staining.	A	spacer	made	of	a	wax	and	Vaseline	mixture	was	used	to	place	the	cover	slip	on	the	drop	to	prevent	the	disruption	of	the	oocyte	structure.			Microscope	slides	were	imaged	using	Zeiss	LSM710	confocal	microscope,	with	Zeiss	Plan-Apochromat	63x/1.4	Oil	DIC	lens.	Various	images	were	taken	using	immunofluorescent	lights	detecting	Texas	Red,	and	DAPI.				
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Table	2.	Antibodies	and	their	associated	species	and	dilutions	used	for	
immunostaining	of	GV	and	M2	oocytes.	All	antibodies	diluted	in	PBS:		
Primary	Antibody	 Description	 Species	
Reactivity	
Dilution	
ATM	 Rabbit	Polyclonal	 Mouse,	Human	 1:200	ATM-Phosphorylated	 Rabbit	Monoclonal	 Human	 1:200	
Secondary	Antibody	 Description		 Species	
Reactivity	
Dilution	
TexasRed	 Goat	 Rabbit	 1:200		 	
Image	Analysis	Image	analysis	was	performed	using	the	software	ImageJ.	(Rasband	WS,	1997)	Manual	assessment	of	ATM,	ATM-P,	and	MRE-11	foci	was	performed	after	adjusting	the	brightness/contrast	levels	for	optimal	viewing.	The	overlapping	colors	of	the	blue	DAPI	and	Texas	Red	associated	with	the	primary	antibodies	resulted	in	a	purple-like	color	indicating	the	presence	of	DNA	damage	response	markers	at	chromosomes.	Images	were	evaluated	for	both	the	overall	presence	of	ATM	and	ATM-P	by	counting	the	total	Texas	Red	foci,	as	well	as	the	presence	of	ATM	and	ATM-P	at	chromosomes	by	counting	the	number	of	DAPI	and	Texas	Red	foci	overlapping.		
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Statistical	Analysis		 The	study	was	single	blind	between	measurements	of	DDR	foci	and	clinical	data.	After	prospective	sample	collection	was	complete,	de-identified	accession	numbers	were	used	to	obtain	any	relevant	clinical	data.	Data	analysis	was	conducted	using	GraphPad	Prism	Version	6	Software.	(2016	GraphPad	Software,	Inc)	The	data	was	collected	from	2	different	experiments	using	ATM	antibody	and	ATM-P	antibody.	Differences	in	foci	number	between	GVs	and	M1/M2	samples	were	evaluated	using	paired	t-tests,	as	well	as	an	evaluation	of	the	mean.	Samples	with	a	P	value	of	less	than	0.05	were	considered	statistically	significant.			 	
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RESULTS			 The	role	of	ATM	was	investigated	in	GVs	and	M1/M2	oocytes	by	comparing	the	difference	in	foci	number	in	each.	GV	(n=6)	and	M1/M2	(n=6)	samples	were	stained	with	anti-ATM	antibody	to	reveal	the	amount	of	expression	within	the	cells.	(Figure	7)	Following	image	analysis	and	statistical	analysis	using	a	paired	t-Test	it	was	found	that	the	difference	in	total	expression	of	ATM	between	GVs	and	M1/M2	oocytes	was	not	significant	(P=	0.2177).		
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Figure	9:	GV	oocyte	stained	with	anti-ATM	antibody	and	DAPI.	Red	foci	indicate	presence	of	ATM	within	the	cell	and	blue	foci	indicate	the	location	of	DNA	within	the	nucleus	of	the	cell.	The	lack	of	overlapping	red	and	blue	foci	indicates	that	ATM	is	only	being	expressed	within	the	cytoplasm.				 Additionally	the	appearance	of	ATM	at	the	chromosomes,	indicated	by	overlapping	red	and	blue	immunofluorescence	was	found	to	be	minimal.	GV	arrested	oocytes	showed	an	average	of	1.33	overlapping	foci	while	M1/M2	oocytes	showed	an	average	of	0.67	overlapping	foci.	(Figure	8)	The	difference	in	the	number	of	co-localized	ATM	and	DAPI	foci	between	arrested	GV	oocytes	and	M1/M2	oocytes	was	also	not	significant.	(P=	0.1381)	(Figure	9)		The	expression	of	ATM-P	between	GVs	(n=5)	and	M1/M2	(n=11)	samples	was	evaluated	after	immunostaining	and	image	analysis.	The	number	of	red	foci	within	the	cell	represented	total	ATM-P	expression.	The	average	number	of	ATM-P	foci	in	GVs	was	found	to	be	significantly	higher	than	M1/M2	oocytes.	(Figure	9)	GVs	had	an	average	of	11.8	total	ATM-P	foci,	while	M1/M2s	had	an	average	of	7.9	total	foci.	(P=0.0496)	(Figure	8)	GVs	showed	a	49%	increase	in	ATM-P	from	M1/M2	oocytes.	
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Figure	10:	Co-localized	immunostaining	of	anti-ATM	antibody	and	DAPI.	Red	circles	indicate	areas	of	both	ATM	and	DAPI	staining.	Foci	are	represented	by	a	pink/purple	color.		
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Figure	11:	Appearance	of	ATM/ATM-P	Foci	in	Human	Oocytes	with	statistical	P	
values.	X-axis	represents	both	maturation	stage	of	oocyte	and	the	evaluated	staining.	Y-axis	represents	average	number	of	foci	in	each	category.	Statistical	P	values	are	represented	above	compared	categories	(Paired	T-test).	GV	arrested	and	M1/M2	oocytes	showed	no	overlapping	staining	of	ATM-P	and	DAPI.		 	
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Figure	12:	Confocal	Microscopy	Images	of	GV	vs.	M2	Staining	with	anti-ATM-P	
antibody	and	DAPI.	GV	oocytes	show	a	significantly	higher	number	of	ATM-P	related	foci	compared	to	M2	oocytes.				 The	total	number	of	oocytes	stained	with	ATM-P	and	DAPI	was	16.	None	of	the	images	showed	signs	of	overlapping	foci	in	either	GV	arrested	(n=5)	or	M1/M2	oocytes	(n=11).	All	red	foci	were	located	in	the	cytoplasm.	This	resulted	in	a	mean	value	of	0	for	the	total	number	of	foci.	(Figure	11)	(Figure	12)			
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Figure	13:	Absent	colocalization	of	ATM-P	antibody	and	DAPI.	All	samples	stained	with	ATM-P	showed	no	signs	of	staining	at	the	nuclear	DNA.	Blue	staining	represents	nuclear	DNA	and	red	staining	represents	ATM-P.		
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Figure	14:	All	values	of	Individual	Number	of	ATM/ATM-P	Foci	in	Human	
Oocytes.	Representation	of	all	values	of	number	of	foci	representing	ATM,	ATM-P,	and	ATM	colocalized	with	DAPI,	and	ATM-P	colocalized	with	DAPI	for	both	GVs	and	M1/M2	oocytes.	All	values	for	ATM-P	at	DAPI	for	both	stages	are	0.					
	 	
	32 
DISCUSSION			 As	women	increasingly	delay	attempts	at	achieving	pregnancy,	an	increasing	amount	of	women	have	turned	to	ART	methods	to	successfully	conceive.	While	ART	may	increase	the	chances	of	fertility,	as	a	woman	ages	past	35,	the	likelihood	of	achieving	a	successful	pregnancy	from	non-donor	oocytes	declines	significantly.			 Oocyte	competence	plays	a	major	role	in	the	likelihood	of	progression	through	maturation,	achieving	successful	fertilization	and	ultimately	pregnancy.	Oocyte	competence	is	affected	by	various	factors	including	DNA	damage	from	exogenous	stressors	on	the	cell.	DSBs	are	the	most	common	and	debilitating	of	the	types	of	DNA	damage,	and	induce	a	specific	and	complex	response	pathway	to	either	repair	the	cell,	induce	apoptosis,	or	cellular	senescence.	GV	cells	are	arrested	at	prophase	of	meiosis	I,	and	are	particularly	susceptible	to	DNA	damage.	Cellular	senescence	at	the	GV	stage	can	be	detrimental	to	reproduction,	preventing	oocytes	from	progressing	the	mature	stage	capable	of	fertilization.		 While	many	studies	have	evaluated	the	DDR	in	mouse	oocytes,	few	studies	have	assessed	the	DDR	markers	that	may	play	a	role	in	cell	cycle	arrest	in	human	oocytes.	By	comparing	the	presence	of	DDR	markers	during	the	latest	stages	of	oocyte	development,	we	are	able	to	identify	certain	markers	that	may	play	a	role	in	cell	cycle	arrest	at	the	GV	stage	of	oocyte	maturation.	As	ATM	is	a	major	regulator	of	the	DDR	pathway	and	cell	cycle	checkpoint	progression,	we	studied	its	presence	within	oocytes	at	various	stages	of	maturation.	ATM	is	a	ubiquitously	expressed	
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protein	amongst	cells,	while	ATM-P,	the	phosphorylated	version	of	ATM,	is	expressed	in	response	to	DNA	damage.		
Ubiquitous	expression	of	ATM	between	GVs	and	M1/M2	Oocytes		 As	we	expected,	ATM	was	expressed	universally	throughout	meiosis.	It	was	found	both	in	GVs	and	M1/M2	oocytes.	The	number	of	foci	representing	the	total	expression	of	ATM	showed	no	significant	difference	between	GVs	and	those	that	had	matured	to	further	stages.	DNA	damage	signal	amplification	results	in	the	phosphorylation	and	activation	of	ATM,	which	is	localized	at	the	site	of	the	DSB.	Our	date	is	thus	consistent	with	the	idea	that	levels	of	ATM	should	not	differ	depending	on	the	meiotic	stage	of	the	oocyte.		In	addition,	the	number	of	foci	representing	overlapping	ATM	and	DAPI	also	did	not	show	a	significant	difference	between	the	various	stages.			
Significant	Difference	in	ATM-P	expression	between	GVs	and	M1/M2	Oocytes		 Our	data	showed	that	the	total	expression	of	the	phosphorylated	version	of	ATM	was	higher	in	GVs	than	in	oocytes	in	more	mature	stages.	This	suggests	that	ATM-P	exists	at	higher	levels	in	oocytes	that	have	been	arrested	for	over	24	hours.	ATM-P	is	a	central	regulator	of	the	cell	cycle,	thus	our	data	suggests	that	it	may	play	a	negative	role	in	the	maturation	of	GVs	to	meiosis	I	in	human	oocytes.			
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	 As	ATM-P	localizes	at	sites	of	DNA	damage	our	results	suggest	a	higher	level	of	DSBs	in	GVs	compared	to	M1/M2	oocytes.	This	would	explain	the	permanent	arrest	of	GVs	and	the	limitation	they	place	on	reproductive	performance.		
Lack	of	ATM-P	Foci	at	Chromosomes		 We	observed	that	the	total	level	of	ATM-P	was	higher	in	GVs	compared	to	M1/M2	oocytes,	but	there	was	a	lack	of	ATM-P	foci	at	chromosomes	at	all	stages	of	maturation.	While	ATM-P	localizes	at	sites	of	DNA	damage,	its	absence	on	sites	of	DAPI	staining	suggest	that	the	existing	ATM-P	foci	may	be	associated	with	other	cytoplasmic	structures.	Neither	GVs	nor	M1/M2	oocytes	showed	signs	of	ATM-P	at	chromosomes,	which	suggest	that	the	role	ATM-P	plays	in	the	DDR	is	consistent	for	all	stages	of	maturation.		 Previous	studies	in	mouse	oocytes	have	found	that	ATM	expression	was	low	in	response	to	induced	DSBs.	Our	data	is	consistent	with	these	findings	in	human	oocytes.	These	studies	also	found	other	DDR	factors	to	be	responsible	for	the	phosphorylation	of	H2AX	at	sites	of	damage,	and	initiating	the	DDR.	Our	data	also	suggests	that	H2AX	phosphorylation	is	ATM-independent	in	human	oocytes	due	to	the	lack	of	ATM	presence	at	the	nuclear	DNA.			
Other	DDR	Markers	to	Evaluate	
	 Past	studies	in	mice	have	found	that	while	ATM	is	ubiquitously	expressed	in	oocytes,	a	significant	amount	of	DSBs	must	occur	to	result	in	its	activation.	ATM	
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inhibition	in	mouse	oocytes	has	been	found	to	have	no	effect	on	the	number	of	phosphorylated	H2AX	foci	along	with	MDC1	in	GV	stage	oocytes	and	M1,	concluding	that	ATM	is	unessential	for	maturation	during	meiosis.	This	is	seemingly	consistent	with	our	findings.		 Various	other	factors	have	been	found	to	play	essential	roles	in	H2AX	phosphorylation	in	mouse	oocytes.	These	include	ATR,	which	phosphorylates	H2AX	in	response	to	hindered	DNA	replication	in	somatic	cells.	(Ward	&	Chen,	2001)	ATR	has	been	found	to	be	involved	in	H2AX	phosphorylation	during	meiotic	maturation.	Another	essential	factor	in	the	DDR	in	mouse	oocytes	is	MRE11.	MRE11	recently	has	been	shown	to	be	essential	for	H2AX	phosphorylation	in	M1	mouse	oocytes,	but	not	M2	oocytes.	Additionally,	the	inhibition	of	MRE11	in	mice	increases	the	observed	number	of	DSBs	in	M2	eggs.	(Mayer	et	al.,	2016)	Future	studies	should	examine	the	role	of	MRE11	in	the	DDR	of	human	oocytes.		 As	our	data	indicate	that	ATM	expression	and	activation	is	low	in	human	oocytes,	consistent	with	recent	findings	in	mice	that	H2AX	phosphorylation	in	M1	is	ATM-independent.	Future	studies	of	the	relative	presence	of	factors	such	as	ATR	and	MRE11	will	reveal	the	role	they	play	in	H2AX	phosphorylation	and	cell	cycle	arrest	at	the	GV	stage.		 Additionally	the	study	of	p21	and	p53,	novel	markers	of	the	cellular	senescence	pathway,	would	provide	insight	to	the	pathway	leading	to	the	permanent	arrest	of	certain	GVs.	A	high	presence	of	these	factors	would	suggest	that	the	DDR	is	in	fact	responsible	for	cell	cycle	arrest.		
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Limitations	of	Study		 Limitations	of	this	study	include	its	small	sample	size.	This	is	due	to	using	discarded	human	oocytes	collected	from	IVF	cycles	in	a	fertility	center.	Even	a	large	fertility	center,	such	as	that	at	NYULMC,	makes	it	difficult	to	access	oocytes.		Additionally	as	this	study	was	performed	throughout	the	months	of	November	to	February,	it	overlapped	with	a	period	when	the	IVF	laboratory	was	closed	for	three	weeks	during	the	period	of	holiday	cleaning.		
Future	Investigations		 To	continue	this	course	of	study	it	would	be	beneficial	to	further	characterize	the	difference	between	DNA	damage	in	GVs	and	M1/M2	oocytes.	Previous	experiments	have	found	increased	telomere	attrition	in	GV	oocytes.	(Kalmbach,	Antunes,	Kohlrausch,	&	Keefe,	2015)	Telomere	shortening	due	to	the	loss	of	telomere	DNA	repeats	throughout	the	lifetime	of	an	organism	results	in	senescence,	apoptosis,	and	genomic	instability.	(de	Lange,	2010)	Telomere	shortening	is	mediated	by	several	mechanisms,	one	of	which	employs	the	DDR	to	excise	telomere	repeats	in	response	to	oxidative	stress.	The	Telomere	Theory	of	Reproductive	Senescence	suggests	that	telomere	shortening	is	enhanced	during	the	prolonged	time	between	birth	and	ovulation	due	to	chronic	exposure	to	reactive	oxygen	species.	(Keefe,	Marquard,	&	Liu,	2006)	
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It	would	be	valuable	to	assess	the	signs	of	DDR	at	chromosome	ends	in	GV	arrested	versus	M1/M2	oocytes.	Since	arrested	oocytes	have	deprotected	telomeres	susceptible	to	DNA	damage,	DDR	markers	such	as	ATM,	ATR	or	MRE11	would	target	DSBs	at	telomere	DNA.	This	would	result	in	colocalization	of	γH2AX	with	telomere-specific	proteins.	In	addition	a	study	of	the	average	telomere	length	of	GV	arrested	versus	M1/M2	oocytes	alongside	immunostaining	for	DDR	markers	would	conclude	if	the	DDR	is	more	active	in	cells	with	shorter	telomeres	leading	to	cell	cycle	arrest.		Immunostaining	using	antibodies	against	the	various	other	markers	of	DSBs	and	cell	cycle	arrest,	including	MRE11,	ATR,	p21,	p53	would	provide	insight	into	the	complex	DDR	occurring	in	GVs	compared	to	oocytes	that	successfully	mature	in	vitro.	In	addition,	inhibition	of	these	proteins	and	measuring	levels	of	H2AX	phosphorylation	would	clarify	which	are	more	active	in	the	various	stages	of	maturation.	Further	study	of	the	level	of	expression	of	SASPs	in	GV	stage	oocytes	in	contrast	with	matured	oocytes	can	provide	more	insight	to	the	connection	between	early	meiotic	arrest	and	the	cellular	senescence	pathway.		Overall	these	studies	along	with	our	own	have	shown	that	GV	arrested	oocytes	present	a	difficulty	to	achieving	pregnancy.	A	further	understanding	of	the	complex	mechanisms	involved	in	early	meiotic	arrest	is	vital	to	improving	the	current	methods	of	ART	and	consequently	increasing	rates	of	successful	pregnancies	in	both	spontaneous	and	IVF	cycles.	Increased	knowledge	on	the	
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mechanisms	behind	GV	arrest	can	provide	insight	into	methods	of	recovering	immature	oocytes	for	potential	use	in	IVF	cycles.	This	would	provide	an	attractive	alternative	to	current	IVF	treatment	due	to	decreased	gonadotropin	administration	and	thus	decreased	risk	of	OHS,	decreased	cost,	and	increased	convenience.			
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